NCT04260555 - Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

December 9, 2019

Study Completion Date

February 28, 2021

Conditions

Acute Bronchitis

Interventions

DRUG

DW1601

Total 7 days of treatment and The daily dose is tid. (DW1601 20ml + Placebo of DW16011 20ml + Placebo of DW16012 9ml)

DRUG

DW16011

Total 7 days of treatment and The daily dose is tid. (Placebo of DW1601 20ml + DW16011 20ml + Placebo of DW16012 9ml)

DRUG

DW16012

Total 7 days of treatment and The daily dose is tid. (Placebo of DW1601 20ml + Placebo of DW16011 20ml + DW16012 9ml)

Trial Locations (1)

Korea University Guro Hospital, Seoul